Infinium Global Research Transcatheter Mitral Valve Replacement Market | Page 2

Transcatheter Mitral Valve Replacement Market: Trends and Forecast -2023
The Infinium Global Research analyzes the report of Transcatheter Mitral Valve
Replacement Market over the period of 2017 to 2023. This report also provides
detailed qualitative and quantitative analyses of the market dynamics, market size
and future trends in Global Transcatheter Mitral Valve Replacement Market. It will
help a lot of decision makers to develop strategies and find new opportunities in
the Global markets of Transcatheter Mitral Valve Replacement.
The report covers market changing aspects including drivers, restraints,
opportunities, and trends expected to encouragement the expansion of the
Transcatheter Mitral Valve Replacement Market during the said period. The report
also provides market attractiveness analysis, by geography, and market share
analysis, by key players respectively. Some of the prominent participants in the
Global Transcatheter Mitral Valve Replacement Market are Micro Interventional
Devices, Neovasc, Medtronic, Biotronik SE & Co. KG, Colibri Heart Valve, Llc.,
Livanova Plc, Neochord Inc. and Coramaze Technologies Gmbh. According to report
the global transcatheter mitral valve replacement market is projected to grow at a
CAGR of 17.9% over the forecast period of 2017-2023.
For More Details Get Free Few Sample Pages of this Premium Report: -
https://www.infiniumglobalresearch.com/reports/sample-request/138
The mitral valve, also known as the bicuspid valve or left atrio-ventricular valve, is a
dual-flap valve in the heart that lies between the left atrium and the left ventricle.
The mitral valve and the tricuspid valve are known collectively as the atrio-
ventricular valves because they lie between the atria and the ventricles of the
heart. The mitral valve manages blood flow between left atrium and left ventricle;
and prevents backward flow of the blood into left atrium. Mitral regurgitation is
leakage of blood backward through the mitral valve each time the left ventricle
contracts. This is a most common mitral valve disorder that causes abnormal blood
flow. As a remedy for this problem, surgeons use mitral surgical vale repair
procedures or transcatheter replacement methods.
Some of the key driving factors attributing to the growth of this market include
increasing number of patients with mitral valve disorders. Approximately 7 million
people in the U.S. suffer from mitral regurgitation in the U.S., and they represent
almost 2% of the nation's population. Similarly, approximately the same number of
people suffers from the condition in Europe. This group includes 4.1 million people
who have moderate to severe mitral regurgitation. The number of new patients
2
© Infinium Global Research